Group of Lab Members
Prof. Anupam Basu at the Panel Discussion event of the 44th Annual Meeting of the Indian Association for Cancer Research (IACR, Kolkata, Organized by IACR, January 16-18, 2025
Prof. Anupam Basu delivered a talk at the Society of Inflammatory Research-India (SIR), organized by SIRCON 2024
Banani Majumdar Received the Best Poster Award at 44th Annual Meeting of the Indian Association for Cancer Research (IACR), January 16-18, 2025
Barnali Dolui presented oral at 44th Annual Meeting of the Indian Association for Cancer Research (IACR), January 16-18, 2025
Banani Majumdar got the Conquer Merit Award at the Breakthrough Conference, Japan, organized by American Society of Clinical Oncology (ASCO), August 8-10, 2024
Nibedita Mitra presented poster at 3rd. Translation Research Conference: Erythropoiesis Control and Ineffective Erythropoiesis: From Bench to Beside: Organized by European School of Haematology (ESH), March 3-5, 2023
PROF. ANUPAM BASU
Professor Anupam Basu currently holds the position of Professor at the University of Burdwan, WB, India. He was also the Associate Director of National Institute of Biomedical Genomics, (NIBMG), India. Anupam conducted postdoctoral research at the Health Science Center, University of New Mexico, USA, and obtained his PhD from the National Institute of Health and Family Welfare (NIHFW), New Delhi.
Professor Anupam's current research focuses on the genomics of Thalassemia and rare genetic disorders. He previously coordinated a multi-centric project, funded by the Department of Biotechnology (DBT, Government of India), on the genetic profile and phenotype correlation of Thalassemia and sickle cell anemia. Presently, his team has developed a genomics panel for Thalassemia, specifically targeting mutation hot spots of the Beta Globin gene within the Indian population. They have also created a field-based Thalassemia carrier screening kit for point-of-care centers, funded by BIRAC, Government of India. This is also under IPR /patent Furthermore, his team is actively engaged in research on the genomics profile of rare disorders.